In Brief: St. Jude Aegis
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Aegis: First European implants of the cardioverter-defibrillator takes place in two patients at University Hospital Zurich in Switzerland and one patient at Na Homolce Hospital in Prague, Czech Republic, the St.Paul, Minnesota firm announces. Designed to treat ventricular tachycardia and fibrillation, the Aegis is "one of the smallest ICDs on the market" according to St. Jude, with a volume of 60 cc and a 16 mm profile. U.S. clinicals of the Aegis began in July ("The Gray Sheet" July 15, In Brief)...